bacterial infections

Vienna-based biotech company, PhagoMed Biopharma, has received more than €4 million in grants and private investments, which will be used to boost the development of alternative therapies to combat antibiotic-resistant bacteria.more

Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with good manufacturing practuces (GMP).more

Findings published in Nature Communications from nanoengineers at the University of California San Diego, have demonstrated the success of drug delivery by micromotors to treat bacterial infections in the stomach.more